APA (7th ed.) Citation

K, I., T, N., K, T., Y, O., T, K., H, I., . . . K, I. (2018). High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis. Dove Medical Press.

Chicago Style (17th ed.) Citation

K, Ishikawa, et al. High Bone Turnover Status as a Risk Factor in Symptomatic Hypocalcemia Following Denosumab Treatment in a Male Patient with Osteoporosis. Dove Medical Press, 2018.

MLA (8th ed.) Citation

K, Ishikawa, et al. High Bone Turnover Status as a Risk Factor in Symptomatic Hypocalcemia Following Denosumab Treatment in a Male Patient with Osteoporosis. Dove Medical Press, 2018.